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Over the past few decades, a high number of pharmaceuticals have been detected in surface, ground and 
drinking waters. This contamination comes from domestic sewage, livestock, hospitals and chemical-
pharmaceutical industries. Typical examples of these pollutants are the fluoroquinolones - powerful 
antibiotics used in human and veterinary medicine. The presence of fluoroquinolones in the environment can 
pose a serious threat to the ecosystem and to human health due to their high consumption globally: in 1998, 
around 120 tons were produced. Even at low environmental concentrations, antibiotics stimulate bacterial 
resistance. The consequences of the presence of fluoroquinolones in the environment are not fully understood, 
but are known to be toxic to plants and aquatic organisms. Approximately 85% of the fluoroquinolones 
present in influents can be removed by conventional wastewater treatment plants, but the removed fraction 
is frequently accumulated in the sludge, which is sometimes used as fertilizer, representing an additional 
input route into the environment. The removal of fluoroquinolones by biological treatment is ineffective, 
and it is believed that only advanced oxidation technologies are able to destroy these emerging pollutants.
Uniterms: Fluoroquinolones/waste/environmental impact. Fluoroquinolones/waste/environmental 
contamination. Environmental contamination. Advanced oxidation processes/wastewater treatment.
Nas últimas décadas, um grande número de fármacos tem sido identificado em águas superficiais, 
subterrâneas e potáveis. Tal contaminação advém do esgoto doméstico, hospitais, criação de animais 
e das indústrias químico-farmacêuticas. Exemplos típicos desses poluentes são as fluoroquinolonas – 
potentes antibióticos empregados na medicina humana e veterinária. A presença de fluoroquinolonas 
no meio ambiente pode representar uma séria ameaça para o ecossistema e para a saúde humana devido 
ao alto consumo mundial: em 1998 foram produzidas, aproximadamente, 120 toneladas. Mesmo em 
baixas concentrações, antibióticos podem estimular a resistência bacteriana. As consequências da 
presença de fluoroquinolonas no ambiente não são completamente compreendidas, mas sabe-se que são 
tóxicas para plantas e organismos aquáticos. Aproximadamente 85% das fluoroquinolonas presentes em 
efluentes podem ser removidos em estações de tratamento de efluentes convencionais, porém a fração 
removida é frequentemente acumulada no lodo, muitas vezes usado como fertilizante, o que representa 
uma rota adicional de entrada desses compostos no ambiente. A remoção de fluoroquinolonas por meio 
de tratamento biológico não é eficiente, e acredita-se que somente as tecnologias de oxidação avançada 
sejam capazes de degradar esses poluentes emergentes.
Uniterms: Fluorquinolonas/resíduos/impacto ambiental. Fluorquinolonas/resíduos/contaminação 
ambiental. Contaminação ambiental. Processos oxidativos avançados/tratamento de águas residuais.
INTRODUCTION
Population growth and industrial expansion 
has brought with it worldwide contamination of the 
atmosphere, soil and water. Moreover, there is growing 
awareness of the deterioration of the environment and 
of the need to reverse, or at least, mitigate this process. 
Issues related to the quality of water have been extensively 
discussed in view of this natural resource being essential 
to a broad spectrum of human activities, such as public 
and industrial supply, agricultural irrigation, electricity 
production, leisure and recreation activities besides aquatic 
life preservation (Melo et al., 2009). Pharmaceutical 
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residues present in the environment have prompted studies 
in the industry and academia to assess the effects of bio-
active compounds in the environment (Golet et al., 2002; 
Lin et al., 2010).
Pharmaceuticals are widely used in human and 
veterinary medicine to treat infections, prevent and 
diagnose diseases, and to promote growth and prophylaxis 
in livestock (Fink et al., 2012). After administration 
to humans and animals, a significant portion of the 
pharmaceuticals, from 10 to 90%, is excreted in urine 
and feces in an unchanged form into sewage, depending 
on the drug (Kümmerer et al., 2000; Bila, Dezotti, 2003; 
Kümmerer, 2009a; Pereira et al., 2012), and subsequently 
enter WWTPs, where these compounds are treated, along 
with other organic and inorganic compounds present in the 
sewage (Ikehata et al., 2006; Pereira et al., 2012). 
The continuous entry of drugs into the aquatic 
environment, even at low concentrations, may pose long-
term potential risks to aquatic and terrestrial organisms 
(Klavarioti et al., 2009; Ikehata et al., 2006). 
In 1970, the first report on pharmacologically active 
compounds in the water environment was published (Gosh 
et al., 2009), but the presence of drugs in the environment 
became an emerging concern only in the mid-1990s, when 
new analytical technologies were available (Homem, 
Santos, 2011).
All over the world, drugs such as antibiotics, 
hormones, anesthetics, antidepressants, chemotherapeutic 
agents, X-ray contrasts, anti-inflammatory agents 
(Tambosi, 2008; Ikehata et al., 2006), among others, 
have been detected in wastewaters, sediments and soil, 
as well as different water reservoirs such as surface, 
ground (Bila, Dezotti, 2003), drinking, tap, and ocean 
water at low concentration levels ranging from mg L-1 to 
ng L-1 (Golet et al., 2002; Klavarioti et al., 2009). This 
fact indicates their ineffective removal from water and 
wastewater using conventional treatment technologies 
(Ikehata et al., 2006).
As antibiotics are highly bioactive compounds, 
there are serious concerns over their role in enhancing 
antibiotic resistance among pathogenic bacteria (Gosh 
et al., 2009), rendering current antibiotics ineffective 
in the treatment of numerous diseases (Homem, Santos, 
2011). Antibiotics can also affect the endocrine system 
of fish and be toxic to algae and invertebrates (Guinea et 
al., 2009a, 2009b). Another aspect is that little is known 
about the potential chronic health effects associated with 
long-term ingestion of mixtures of antibiotics through 
drinking water (Ikehata et al., 2006), given that drugs are 
designed to exert an effect on specific biological systems 
(Fink et al., 2012).
Fluoroquinolones are often found in surface 
waters (Pena et al., 2007). This family of antibiotics 
is widely employed in human (since the 1980s) and 
veterinarian (since the 1990s) medicine, due to the 
antibiotics’ rapid bactericidal action against a number of 
common microorganisms. Among these antimicrobials, 
enrofloxacin is the most used drug in veterinary medicine 
(Golet et al., 2002; Guinea et al., 2009a).
Fluoroquinolones are active against  many 
pathogenic bacterial species by selectively inhibiting 
bacterial DNA synthesis. Administered fluoroquinolones 
are largely excreted as unchanged compounds in urine, 
and consequently discharged into hospital or municipal 
sewage (Golet et al., 2002; Pena et al., 2007; Fink et 
al., 2012). These fluoroquinolones are not completely 
removed at WWTPs and consequently, their continuous 
introduction into the environment makes fluoroquinolones 
‘pseudo-persistent’ compounds. The fluoroquinolones, 
initially present in water bodies, rapidly transfer into the 
soil and sediments, due to strong adsorption on minerals 
and organic matter (Sturini et al., 2012).
Besides their potential to promote antibiotic 
resistance, fluoroquinolones also have an unfavorable 
ecotoxicity profile (Golet et al., 2002), and may contribute 
to a significant portion of the measured bacterial 
genotoxicity in hospital effluents (Zhang, Huang, 2005).
HISTORICAL
The first discovered quinolone was the nalidixic 
acid (Lesher et al., 1962), which showed activity only 
against enterobacteria (Nava, 2007). Quinolones emerged 
accidentally, as a by-product of an antimalarial agent 
synthesis, with known and proven antibacterial activity, 
chloroquine. Because nalidixic acid did not reach the 
appropriate concentration in most tissues and organs, its 
indication became restricted to the treatment of simple 
urinary tract infections (Nava, 2007). As a consequence, 
other quinolones have been synthesized and tested that 
broaden the antibacterial spectrum and the usefulness of 
these drugs (Silva, 2004).
The introduction of different functional groups into 
the quinolone structure gave rise to new compounds with a 
broader spectrum of action, better pharmacokinetics, lower 
toxicity, that were capable of outstripping the resistance 
of different microorganisms (Sousa, 2007).
Although many fluoroquinolones have been 
synthesized, the most known and used among this 
group are amilofloxacin, ciprofloxacin, danofoxacin, 
enrofloxacin, marbofloxacin, norfloxacin and sarafloxacin 
(Otero et al., 2001a).
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METABOLISM AND EXCRETION
Fluoroquinolones are eliminated from the body 
primarily by hepatic metabolism and renal excretion. In 
general, fluoroquinolones are partially metabolized in 
the liver and excreted in bile and urine containing high 
active drug concentration (unchanged drug or active 
metabolite) (Otero et al., 2001b). Ciprofloxacin, for 
example, is 65% excreted in urine and only 25% in the 
feces (Krause, 2009).
APPLICATION OF FLUOROQUINOLONES
Currently, quinolones are one of the major classes 
of antimicrobials and are therefore used worldwide in 
the treatment of infections of bacterial origin and in 
therapeutic indications ranging from application in urinary 
tract infections to virtually the whole body (Otero et al., 
2001a) and are very important in the treatment against 
gram negative and gram positive organisms. The latest 
generations of these antimicrobials are active against 
anaerobic bacteria, including those resistant to β-lactam 
antibiotics and sulfonamides, making these drugs useful 
in therapy for a wide range of infections (Silva, 2004). 
Quinolone’s therapeutic action is crucial, especially in 
infections caused by organisms resistant to other classes 
of drugs (Sousa, 2007).
In human medicine, ciprofloxacin and ofloxacin 
are among the most widely used quinolones in hospitals 
(Kümmerer et al., 2000). They are used in the treatment 
of sexually transmitted diseases, bone and joint infections, 
typhoid fever, tuberculosis, among others (Rocha et 
al., 2011). The more recent fluoroquinolones, such 
as gatilofloxacin, moxifloxacin and gemifloxacin, are 
employed in the treatment of acute sinusitis, chronic 
bronchitis, infections of the skin and soft tissues, cystitis, 
pyelonephritis, complicated urinary infections and 
gonorrhea (Lopes, 2004).
Besides their antibacterial activity, studies 
have found that fluoroquinolones inhibit the enzyme 
mammalian topoisomerase II, and are therefore used in 
the development of anticancer and anti HIV drugs (Rocha 
et al., 2011).
CONSUMPTION OF ANTIBIOTICS
Because international data are based only on 
estimates, the true volume of antimicrobial use in the 
agri-food sector is not known. Estimates of the amounts 
of antimicrobials used are conflicting (Bila, Dezotti, 2003; 
Tambosi, 2008; Kümmerer, 2009a).
Antibiotic consumption worldwide in 2003 was 
estimated to lie between 100,000 and 200,000 tons per year 
(Tambosi, 2008). In 1996, about 10,200 tons of antibiotics 
were used in the European Union, of which around 
50% was applied in veterinary medicine and as growth 
promoters. In 1999, a total of 13,216 tons of antibiotics 
were used in the European Union and Switzerland, 65% 
of which was applied in human medicine. In the United 
States, one estimate is that 50% of the 22,700 tons of all 
antimicrobials prescribed annually are for humans and 
50% for use in animals, agriculture and aquaculture. A 
more recent report estimated that livestock producers 
in the United States use approximately 11,200 tons of 
antimicrobials for non-therapeutic purposes primarily to 
promote the growth of cattle, hogs, and poultry. Clinical 
uses are estimated at about 10% of total antimicrobial use 
(Kümmerer, 2009a; Sukul, Spiteller, 2007).
Considering the United States, European Union, 
Japan and South Korea, quinolone production and usage 
is around 50 tons in the form of proprietary products and 
70 tons as generic quinolones; 1998 estimates of annual 
quinolone consumption for humans and animals in China 
were about 1,350 and 470 tons, respectively (Sukul, 
Spiteller, 2007).
ENVIRONMENTAL OCCURRENCE
Until recently, pharmaceutical compounds in the 
environment have drawn very little attention. Although 
their presence in the effluents of WWTPs had been 
reported, it was believed these compounds were easily 
biodegradable in the environment as most could be 
metabolized and transformed to some extent in humans 
(Kümmerer et al., 2000; Ikehata et al., 2006). However, 
a large number of recent studies have demonstrated 
the persistence of these pharmaceuticals in the aquatic 
environment (Ikehata et al., 2006). 
Scientific interest in the issue of “pharmaceuticals 
in the environment” was awakened in the 1970s. The 
main information gleaned from this period was that these 
substances have low biodegradability. During the 1980s, the 
spotlight of environmental science turned away to focus on 
a series of other compounds, leaving the drugs somewhat 
forgotten. Since the mid-90s however, research on this 
topic has risen again, along with discussions involving 
chemicals which act as endocrine disruptors. Subsequently, 
the occurrence, effects and risks of these species in the 
environment have been investigated (Vasconcelos, 2006).
Studies show that pharmaceuticals and their 
metabolites are present in aquatic environments in many 
parts of the world including Germany, Brazil, Canada, 
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Holland, England, Italy, Sweden, the United States, the 
United Kingdom (Bila, Dezotti, 2003; Ikehata et al., 
2006; Tambosi, 2008), Spain (Gros et al., 2010), France, 
Switzerland, Greece (Melo et al., 2009), Japan (Gosh 
et al., 2009), Austria (Regitano, Leal, 2010), and China 
(Guinea et al., 2009a).
In the environment, there are three possible fates for 
any given drug: (1) it may be biodegradable, and therefore 
become mineralized into carbon dioxide and water; (2) it 
may undergo particular metabolic processes or be partially 
degraded; or (3) it may be persistent (Bila, Dezotti, 2003).
Figure 1 shows possible pathways for antibiotics, 
after being discarded into the environment (Bila, Dezotti, 
2003):
Because of the extensive usage of fluoroquinolones, 
the presence and accumulation of fluoroquinolone 
antibacterial agents in aquatic environments have 
been widely reported; for example 249-405 ng L-1 of 
ciprofloxacin and 45-120 ng L-1 of norfloxacin were 
detected in domestic sewage in Switzerland (Golet et al., 
2002; Fink et al., 2012). Higher concentrations of some 
fluoroquinolones (0.6-2 μg L-1) were also detected in 
wastewaters in the United States. Median concentrations of 
0.02 μg L-1 and 0.12 μg L-1 were reported for ciprofloxacin 
and norfloxacin, respectively, for samples from 139 
surface streams across the United States. Additionally, 
ciprofloxacin in the range 0.7-124.5 μg L-1 was found in 
wastewater of a Swiss hospital (Fink et al., 2012). 
Ciprofloxacin and norfloxacin were detected in 
sewage and at WWTPs in Switzerland in the range 
45-568 ng L-1 and 36-367 ng L-1, respectively. The removal 
efficiency of these drugs in WWTPs was in the range 
79-87% (Golet et al., 2002; Kümmerer et al., 2000). 
Table I contains data on fluoroquinolone concentrations 
in the environment worldwide.
WWTP sludge and sediments
Due to the presence of several ionizable groups and 
the ability to form cationic, anionic or zwitterionic species, 
fluoroquinolones have a high tendency for sorption in soils 
and sediments, but this does not mean the compounds lose 
their antimicrobial activity (Pereira et al., 2012). Sorption 
is influenced by the properties of the soil, such as pH, 
organic carbon content, metal oxide content, ionic strength 
and cation-cation exchange capacity (Aga, 2008).
The main route for degradation of veterinary 
antibiotics in soils is via aerobic biodegradation. Degradation 
rates in soil vary, with half-lives ranging from days to years. 
Of the quinolones, olaquindox can be considered only 
slightly persistent (half-life 6 to 9 days), while danofloxacin 
is very persistent (half-life 87 to 143 days) (Aga, 2008).
FIGURE 1 - Possible routes of antibiotics into the environment (Adapted from Bila, Dezotti, 2003; Ikehata et al., 2006; Homem, 
Santos, 2011).
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TABLE I - Environmental concentrations of fluoroquinolones (Vasconcelos, 2006; Tambosi, 2008; Melo et al., 2009; Gosh et al., 
2009; Regitano and Leal, 2010)
Pharmaceutical
Average 
concentration 
(µg L-1)
Matrix
Ciprofloxacin
0.26 Raw sewage/Italy
0.097 WWTP effluent/Italy
0.06 WWTP effluent/France
0.07 WWTP effluent/Greece
0.03 WWTP effluent/Sweden
0.037 WWTP effluent/Switzerland
0.02 Surface water/USA
0.28 Chicken manure/UK
0.5.10-3 Surface water/Germany
3-87 Hospital effluent/Switzerland
14.5 Hospital effluent/Switzerland
0.7 – 124.5
Hospital effluent/
Switzerland
2.3 Hospital effluent/Germany
0.6 WWTP effluent/Germany
0.06 Surface water/Germany
0.055 – 0.405
WWTP effluent/
Switzerland
0.434/0.072 Before/after WWTP/Switzerland
0.005 – 0.018
Surface water/
Switzerland
270 – 2.420 Sludge/Switzerland
0.02 – 0.03 Surface water/USA
0.427/0.071 Before/after WWTP/Switzerland
5,300 Activated sludge/Switzerland
0.118 – 0.4
WWTP effluent/ 
Canada
Pharmaceutical
Average 
concentration 
(µg L-1)
Matrix
Ciprofloxacin
3.6 – 101
Hospital effluent/
Sweden
0.1 – 0.16 WWTP effluent/USA
0.238 – 0.514 WWTP effluent/Italy
0.36 WWTP effluent/Netherlands
0.6 WWTP effluent/France
0.7 WWTP effluent/Greece
0.057 WWTP effluent/Italy
0.03 WWTP effluent/Sweden
15 Hospital effluent/Sweden
0.5 Hospital effluent/Sweden
151,400 Sediment hospital 
effluent/Sweden
0.158/0.018 Before/after WWTP/Sweden
2,540 WWTP sludge/Sweden
0.22/0.048 Before/after WWTP/Sweden
31,200 WWTP sludge/Sweden
6.3 Surface water/Europe
Norfloxacin
0.460  WWTP influent/China
0.085-0.320 WWTP effluent/China
0.155-0.486  WWTP influent/Japan
Enrofloxacin
2,800 Chicken manure/Austria
0.007-0.085  WWTP influent/Japan
Levofloxacin
0.255-0.587  WWTP influent/Japan
0.981  WWTP influent/Japan
Nalidixic acid 0.007-0.040 WWTP influent/Japan
Ofloxacin 0.110-1 WWTP effluent/ USA
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Uptake by plants
Some veterinary antibiotics have the ability to 
transfer from soil to plants. Measurable antibiotic residues 
are present in soil for some months after the application of 
manure containing these compounds. Some of these drugs 
are taken up by vegetables, such as carrot roots (tubers), 
lettuce leaves, green onions, cabbages, cucumbers, 
potatoes and corn. The exposure route may, however, 
be important when veterinary antibiotics have very low 
acceptable daily intake values, when they may cause subtle 
effects over prolonged periods, or when exposure occurs 
via several routes at once (Kümmerer, 2009a; Homem, 
Santos, 2011). 
 Studies have shown that concentrations of 
enrofloxacin of over 100 μg L-1 presented toxicity in roots, 
cotyledons and leaves of several cultivated plant species, 
such as beans, cucumbers, lettuce and radish; plants were 
able to convert part of the enrofloxacin absorbed into the 
enrofloxacin metabolite, ciprofloxacin (Regitano, Leal, 
2010).
ECOTOXICITY
Ecotoxicological data in the open literature are 
available for less than 1% of the drugs, and only a small 
number of these few compounds have been subjected to risk 
assessment using ecotoxicological tests. Pharmaceuticals 
are designed to act on specific organs, tissues, cells or 
biomolecules, or on specific metabolic and molecular 
pathways in human and animals, but also have relevant 
side effects. Drugs introduced into the environment can 
affect animals through the same pathways and act on 
similar functions to those affected in humans. For many 
drugs, the specific effects or modes of action are not well 
known and often, not only one, but several different modes 
of action can occur (Tambosi, 2008). 
Test systems are used to assess the interaction of 
antibiotics and bacteria in the environment. However, 
when several compounds with different activity spectra 
are tested, microbial population dynamics of a population 
may conceal effects on other populations, masking the 
results. In addition, environmental parameters, such as 
pH, temperature, nutrients and light, may be different from 
those tested, as may the quantity and quality of bacteria 
and other microorganisms present (Kümmerer, 2009b).
Toxicity tests are usually conducted at concentrations 
above 1 µg L-1, to assess acute toxicity, while in the 
environment, organisms are exposed continuously 
to low concentrations of several kinds of compounds 
simultaneously, and so chronic effects are most probable, 
besides the possibility of additive or synergic effects of 
this mixture of compounds (Melo et al., 2009).
According to the literature, fluoroquinolones are 
considered highly toxic to bacteria, toxic to algae and 
plants, and considered dangerous to fish and crustaceans 
(Vasconcelos, 2006; An et al., 2010). 
A number of studies on toxicity have been conducted, 
some of which are described below.
Vasconcelos et al. (2009) studied the photo-
degradation of ciprofloxacin, identifying the primary 
by-products, and assessed their biodegradability and 
toxicity. The photo-products were obtained by irradiation 
with a medium-pressure mercury arc lamp. Ciprofloxacin 
showed no effects against Vibrio fisheri at concentrations 
up to 300 µg L-1. The antimicrobial activity against 
bacteria was still present. Thus, the total toxicity of 
remaining ciprofloxacin and formed photo-products 
had been reduced, i.e. the toxicity of the photo-products 
was probably no higher than that of ciprofloxacin itself 
(Vasconcelos et al., 2009). 
Ge et al. (2010) studied the aquatic photochemistry 
of fluoroquinolones and the toxicity of the oxidation 
products as well as luminescence inhibition to Vibrio 
fischeri. The eight fluoroquinolones (ciprofloxacin, 
danofloxacin, levofloxacin, sarafloxacin, difloxacin, 
enrofloxacin, gatifloxacin, and balofloxacin) exhibited 
similar toxicities. During photodegradation, the toxicities 
first decreased, then increased, and finally decreased, 
implying the generation of some intermediates of greater 
toxicity than the parent compound. In natural water 
bodies, the levels of fluoroquinolones are usually lower 
than the concentrations employed in the study. Thus, the 
fluoroquinolone concentrations may have been too low 
to exhibit their photomodified toxicities (Ge et al., 2010).
Li et al. (2011) studied the photolysis of enrofloxacin 
in water under simulated sunlight irradiation using a Xenon 
lamp. The toxicity of enrofloxacin and its degradation 
products during the irradiation were evaluated using the 
Vibrio fischeri test. The results showed the generation of 
some intermediates that were more toxic in comparison 
to the parent compound, followed by the degradation of 
the most toxic intermediates.
 During the first hour, the increased toxicity may 
have resulted from the degradation products. LC–MS 
analysis showed that some groups were detached from 
the quinolone moiety of enrofloxacin. These group losses 
resulted in a lower steric hindrance and easier penetration 
into the cell of luminescent bacteria, which subsequently 
led to the increase in toxicity. One hour later, the toxicity of 
the products decreased, suggesting the intermediates were 
degraded to some less toxic products. During irradiation, 
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the mixed products first showed increasing toxicity and 
then decreasing toxicity to the luminescent bacteria (Li 
et al. 2011).
Yuan et al. (2011) studied the photodegradation and 
toxicity of the antibiotics oxytetracycline, doxycycline and 
ciprofloxacin in the UV and UV/H2O2 process. Toxicity 
of the three antibiotics and their reaction samples was 
evaluated using Vibrio fischeri. Toxicity increased during 
UV photolysis when the characteristic structure of the 
parent compounds was preserved. In the UV/H2O2 process, 
toxicity first increased and then decreased, where nontoxic 
products were formed by the oxidation of hydroxyl radical. 
An increased toxic effect occurred in UV direct photolysis 
with the decay of the target compounds. In the UV/H2O2 
process, the toxicity initially increased and then decreased 
to no measurable toxicity. Based on these results, the 
oxidation of the three antibiotics could be better explained 
if divided into two stages: the first stage, comprising the 
degradation of the parent compounds causing increased 
toxicity of by-products; and the second stage, in which 
the more toxic by-products were further converted into 
non-toxic by-products (Yuan et al., 2011). 
BIODEGRADABILITY
Antibiotics generally show low biodegradability 
since they are biocides whose degradation cannot 
be accomplished in the environment or at WWTPs 
(Balcioglu, Ötker, 2004).
Some antibiotics found in the soil and sediments 
proved to be very persistent in laboratory tests as well as 
in field studies. Some do not biodegrade well under aerobic 
or anaerobic conditions (Kümmerer, 2009a).
Kümmerer et al. (2000) studied the biodegradability 
of some antibiotics, including ciprofloxacin and ofloxacin. 
None of the test compounds were biodegraded to any 
extent in this test system. Therefore, none of the antibiotics 
listed above can be classified as “readily biodegradable”. 
In the test controls with ciprofloxacin and ofloxacin, an 
inhibition of biodegradation was observed within the first 
few days of the test. This inhibition disappeared after 8 
and 11 days, respectively. Furthermore, the quinolones 
ciprofloxacin and ofloxacin showed high genotoxic 
activity. In an aquatic model ecosystem, the elimination of 
ciprofloxacin took place by adsorption onto the sediment, 
but the mineralization process was relatively slow. 
Sarafloxacin, a fluoroquinolone registered for use against 
poultry diseases, was mineralized by less than 1% in 
various soils within 80 days, probably because of its strong 
binding to soil. Ciprofloxacin was not biodegradable in a 
closed bottle test. In general, only low degradation rates 
may occur in surface waters and sediments (Kümmerer 
et al., 2000). 
Vasconcelos et al. (2009) studied the biodegradability 
of primary by-products generated by photolysis of 
ciprofloxacin. The initial concentration of the antibiotic was 
100 μg L-1, a level similar to that found in wastewaters of 
the Hospital of the University of Santa Maria, Brazil. The 
samples were submitted to the closed bottle test in order to 
obtain biodegradability information about the by-products 
formed during the photo-process. The irradiated samples 
exhibited no difference in comparison to those prior to 
treatment, showing that the photo-process did not increase 
the biodegradability or toxicity against the bacteria present. 
The presence of a secondary carbon source may sometimes 
improve biodegradability. However, a test showed that the 
photo-products formed were not biodegradable even in 
the presence of a secondary readily biodegradable carbon 
source (Vasconcelos et al., 2009).
ACTION INVOLVING MICROORGANISMS, 
PLANTS, BIOACCUMULATION, AND NATU-
RAL DEGRADATION
Pharmaceuticals which persist after treatment at 
WWTPs may affect organisms of different trophic levels. 
For example, in a model aquatic system using synthetic 
fresh water, nitrifying bacteria were affected by an 
aquaculture antibiotic (Kümmerer, 2009a). 
Bacteria, fungi and microalgae are the organisms 
primarily affected by antibiotics, because antibiotics are 
designed to affect microorganisms. In general, the effects 
of antibiotics on bacteria and microalgae are found to be 2 
to 3 orders of magnitude below the toxic values for higher 
trophic levels (Kümmerer, 2009a).
The sensitivity of algae to antibiotics varies widely. 
Blue-green algae (cyanobacteria) for example, have 
demonstrated sensitivity to many antibiotics, such as 
sarafloxacin. Algae are affected by antibiotics, which in 
turn may affect the balance in aquatic systems, since algae 
are the base of the food chain (Kümmerer, 2009a).
Common receptors have been identified in 
plants for a number of antibiotics affecting chloroplast 
replication (fluoroquinolones), transcription and 
translation (tetracyclines macrolides, lincosamides, 
P-aminoglycosides, and pleuromutilins), metabolic 
pathways such as folate biosynthesis (sulphonamides) 
and fatty acid biosynthesis (triclosan) (Kümmerer, 2009a).
Exposure to antibiotics in the environment may 
have adverse reproductive effects in the early life stages 
of different organisms. A significantly depressed hatching 
rate for Artemia sp. cysts and a high mortality rate for 
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nauplii as well as toxic effects on reproduction of Daphnia 
magna demonstrate how serious the impacts of antibiotics 
on these organisms can be. The capability of altering the 
pigmentation of Artemia salina nauplii, thus resulting in a 
loss of fitness for these individuals was demonstrated for 
the antibiotic flumequine. 
Antibiotics in the environment can also affect the 
behavior of aquatic organisms. 
For instance, it has been shown that antibiotics 
can influence the phototaxis (locomotory movement) of 
Daphnia magna (Kümmerer, 2009a).
Robinson et al. (2005) performed toxicity tests 
with seven fluoroquinolone antibiotics (ciprofloxacin, 
lomefloxacin, ofloxacin, levofloxacin, clinafloxacin, 
enrofloxacin) and flumequine, on five aquatic organisms. 
Overall toxicity values ranged from 7.9 to 23,000 μg L-1. 
The cyanobacterium Microcystis aeruginosa was the most 
sensitive organism, followed by duckweed, and the green 
alga Pseudokirchneriella sub-capitata. Results from tests 
with the crustacean Daphnia magna (48 h survival) and 
fathead minnow (Pimephales promelas, 7-day early life 
stage survival and growth) showed limited toxicity with 
no-observed-effect concentrations at or near 10 mg L-1. At 
an estimated environmental concentration of 1 μg L-1 only 
M. aeruginosa may be at risk in surface water (Robinson 
et al., 2005).
PHYSICAL, CHEMICAL AND BIOLOGICAL 
TREATMENTS
During the last century, many different technologies 
were developed to remove pollutants from urban 
wastewaters,  where they can be present at high 
concentrations of the order of µg L-1 to mg L-1. 
Most conventional wastewater and drinking 
water treatments are based on biological degradation, 
coagulation, flocculation, sedimentation and filtration - 
processes shown to be inefficient for removing/destroying 
pharmaceuticals including antibiotics. Therefore, 
enhancing the development of new and more efficient 
processes is necessary (Balcioglu, Ötker, 2004; Homem, 
Santos, 2011).
High degradat ion  eff ic iencies  of  organic 
contaminants, including fluoroquinolones are obtained 
by AOPs, which can be defined as aqueous phase oxidation 
methods based on highly reactive oxygen species, such as 
hydroxyl radicals (Fink et al., 2012). Advanced oxidation 
and reduction processes typically involve the formation 
of hydroxyl radicals (•OH) as oxidizing species and either 
hydrated electrons (e–aq) or hydrogen atoms (H•) as reducing 
species, all of which can be used in the destruction of 
organic pollutants present in drinking and wastewater 
(Santoke et al., 2009).
AOPs are characterized by a variety of radical 
reactions that involve combinations of chemical agents 
(e.g., O3, hydrogen peroxide, transition metals, and metal 
oxides) and auxiliary energy sources (e.g., UV-VIS 
radiation, electric current, γ-radiation and ultrasound). 
Examples of AOPs include H2O2/UV, Fenton (Fe2+/
H2O2), photo- and electro-Fenton, chelating agent-assisted 
Fenton/photo-Fenton, heterogeneous photo oxidation 
using titanium dioxide (TiO2), γ-radiolysis, and sonolysis 
(Petrovic et al., 2011). When the oxidation agent is 
sufficiently powerful, such as hydroxyl radicals, a complete 
mineralization of pollutants to carbon dioxide, water, and 
inorganic compounds is possible, or at least a conversion of 
the organic pollutants into highly oxidized products which 
are often susceptible to further degradation. 
Hydrogen peroxide is a commonly used auxiliary 
oxidation agent, with reduction potential varying 
with pH. It is not sufficiently strong to oxidize most 
organic pollutants by itself and is therefore often used 
in combination with other reagents, catalysts, or UV 
irradiation which together induce the formation of 
hydroxyl radicals (Fink et al., 2012).
Manganese oxides, commonly found in soils and 
sediments, are among the most important natural reactants 
or catalysts in facilitating organic pollutant transformation. 
On the basis of the strong affinity of fluoroquinolones 
for soils and sediments, there is great potential for 
fluoroquinolones to react with mineral components in such 
systems (Zhang, Huang, 2005).
Previous studies have reported rapid reactions of 
ciprofloxacin and enrofloxacin with chlorine dioxide 
(ClO2) and ozone. Chlorine dioxide is a powerful 
disinfectant that has comparable biocidal efficacy, but less 
pH dependence and disinfection by-product formation 
potential compared to free chlorine, and is a highly 
selective oxidant. The structures of fluoroquinolone 
molecules contain both aliphatic and aromatic amine 
moieties and thus are likely to be susceptible to oxidation 
by ClO2 (Wang et al., 2010).
Heterogeneous catalysis by semiconductors has 
been proven to be highly efficient in organic pollutant 
degradation. It involves the exposure of the semiconductors 
(usually metal oxides) as particles suspended in aqueous 
solutions of the pollutant or as thin films. Among its 
advantages, heterogeneous catalysis offers rapid removal 
of contaminants, less or no polycyclic by-products, and 
degradation of pollutants in the μg L-1 range. The most 
common heterogeneous catalyst is titanium dioxide 
combined with UV irradiation at 300-400 nm. In this 
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method, the semiconductor acts as a sensitizer for light-
induced redox processes. Other semi-conductors such us 
ZnO, ZnS, Fe3O4, Fe2O3, and CuO, have also been found 
to be effective (Fink et al., 2012).
UV/H2O2 has been proposed as an effective 
treatment method for organic contaminants in drinking 
water and reclaimed water. In this process, pollutants are 
degraded in two ways. Some organic chemicals absorb 
UV light directly, causing destruction of chemical bonds 
and subsequent breakdown of the contaminant. However, 
other organic species do not degrade quickly or efficiently 
by direct UV photolysis. Therefore, the addition of H2O2 
is necessary to degrade contaminants more efficiently. 
However, the presence of hydroxyl radical scavengers 
in natural water matrices, including carbonate species 
(HCO3-, CO32-), natural organic matter and other organic 
compounds, could have a negative influence on the 
efficiency of UV/H2O2. Mineralization of trace organic 
compounds is a preferred goal when treating wastewater 
effluents for water reuse applications or drinking water 
from wastewater-impacted sources. However, during these 
wastewater treatments, complete mineralization is often 
unfeasible (Yuan et al., 2011).
Photolysis is one of the most important ways 
of attaining antibiotic elimination in natural aquatic 
environments. In natural waters, humic substances 
and nitrate ions may contribute to the degradation of 
residual drugs, since under exposure to sunlight they are 
able to generate highly reactive species, such as singlet 
oxygen and hydroxyl radicals. On the other hand, humic 
substances absorb a broad range of radiation, thus reducing 
the amount of free energy for other organic molecules 
acting as a filter and thus preventing direct photolysis 
(Melo et al., 2009).
Recently, several studies have been conducted to 
determine the most effective process and the most favorable 
conditions for the degradation of fluoroquinolones. Some 
of these studies are listed below.
Wetzstein et al. (1997) studied the degradation of 
enrofloxacin with the brown rot fungus Gloeophyllum 
striatum. Enrofloxacin at 10 mg L-1 was transformed into 
metabolites after only 1 week. The metabolites formed 
suggested the existence of four main degradation routes that 
may occur simultaneously. Each route, initiated by either 
oxidative decarboxylation, defluorination, hydroxylation at 
C-8, or oxidation of the piperazinyl moiety, may reflect an 
initial attack by hydroxyl radicals at a different site of the 
drug. During chemical degradation of enrofloxacin with 
Fenton’s reagent, five metabolites were identified. These 
findings provide new evidence to support the hypothesis 
that brown rot fungi may be capable of producing hydroxyl 
radicals, which could be used to degrade wood and certain 
xenobiotics (Wetzstein et al., 1997).
Wetzstein et al. (1999) studied the degradation of 
ciprofloxacin by basidiomycetes and the identification of 
metabolites generated by brown rot fungus Gloephyllum 
striatum. Its degradation by basidiomycetous fungi was 
studied by monitoring CO2 production from ciprofloxacin 
in liquid cultures. Sixteen species present in wood, soil, 
humus, or animal dung produced up to 35% CO2 during 
8 weeks of incubation. Despite some low rates of CO2 
formation, all species tested had reduced the antibacterial 
activity of ciprofloxacin in supernatants to between 0 and 
33% after 13 weeks. Gloeophyllum striatum was used to 
identify the metabolites formed from ciprofloxacin. After 
8 weeks, mycelia had produced 17 and 10% CO2 from 
C-4 and the piperazinyl moiety, respectively, although 
more than half of ciprofloxacin (applied at 10 ppm) had 
been transformed into metabolites after 90 h. For the first 
time, these findings revealed the widespread potential 
for ciprofloxacin degradation among basidiomycetes 
dispersed in various environments, including agricultural 
soils and animal dung (Wetzstein et al., 1999).
Balcioglu and Ötker (2004) studied the treatment of 
a simulated enrofloxacin production wastewater with O3, 
O3/H2O2 and O3/UV processes, and the efficiencies of the 
treatment processes were compared by means of chemical 
oxygen demand (COD), absorbance removals, and 
biodegradability enhancement. The results indicated that 
for the treatment by ozonation, pH control is an important 
factor in order to obtain high efficiency treatment. By 
using ozonation at pH = 12, the BOD5/COD ratio was 
improved to 0.5. The introduction of H2O2 did not enhance 
the treatment efficiency of the simulated wastewater. With 
the O3/UV process, the contribution of UV light to the 
overall destruction of benzene rings and biodegradability 
enhancement was high. Consequently, ozonation and 
photolytic ozonation processes seem to be promising 
methods for the pretreatment of antibiotic formulation-
containing wastewaters (Balcioglu, Ötker, 2004).
Zhang and Huang (2005) studied the oxidative 
transformation of fluoroquinolone and structurally 
related amines by manganese oxide. In the study, high 
reaction rates of fluoroquinolones with manganese oxides 
were obtained. Seven fluoroquinolones (ciprofloxacin, 
enrofloxacin, norfloxacin, ofloxacin, lomefloxacin, 
pipemidic acid and flumequine) were examined for 
adsorptive and oxidative interactions with MnO2 under 
environmental conditions. No detectable antimicrobial 
activity was observed for the photodegradation products 
of ciprofloxacin; in contrast, antimicrobial activity against 
Escherichia coli, Enterobacter cloacae, and Klebsiella 
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oxytoca was statistically significant even after increased 
levels of photodegradation for ofloxacin and levofloxacin. 
Dealkylated products have much lower antimicrobial 
activity than the defluorinated products. If the above 
reasoning is indeed correct, the dealkylated oxidation 
products of fluoroquinolones with manganese oxide 
would mean reduction in antimicrobial activity. This study 
strongly suggested that manganese oxides commonly 
present in soils will likely play an important role in the 
abiotic degradation of fluoroquinolones in the environment 
(Zhang, Huang, 2005).
Zhang and Huang (2007) studied the adsorption 
and oxidation of seven fluoroquinolones (ciprofloxacin, 
enrofloxacin, norfloxacin, ofloxacin, lomefloxacin, 
pipemidic acid and flumequine) and structurally related 
amines with goethite. This study demonstrated that 
interactions of fluoroquinolones with Fe oxide were very 
strong over a wide range of environmental conditions, 
and involved both adsorption and oxidation. Adsorption 
of fluoroquinolones onto goethite is strong and fast, 
whereas oxidation continues slowly yielding a range of 
by-products. The carboxylic group of fluoroquinolone 
is critical for adsorption while the piperazinyl ring is 
susceptible to oxidation; both functional groups are present 
in most members of fluoroquinolones. In comparison to 
the work of Zhang and Huang (2005) on the interactions 
of fluoroquinolones with Mn oxide, fluoroquinolones 
have different adsorption sites (piperazine ring versus 
carboxylic group, respectively) but the same oxidation site 
(the piperazine ring) toward Mn and iron oxides. Although 
different adsorption behavior is involved with these two 
oxides, the same radical-based oxidation mechanism is 
present in both cases. Results of this study indicated that 
Fe oxides in aquatic sediments may play an important role 
in the natural degradation of fluoroquinolones (Zhang, 
Huang, 2007).
Guinea et al. (2009a) studied simulated wastewater 
containing enrofloxacin using electrochemical oxidation 
by a diamond conductor, ozonation and the Fenton 
process. The use of electrochemical oxidation by a 
diamond conductor is the most efficient technology 
concerning mineralization. This indicates that ozonation is 
more efficient for destroying complex organic molecules, 
but not for removing carboxylic acids. The high efficiency 
of initial oxidation by the Fenton process shows that this 
process is very efficient in the removal of enrofloxacin, 
despite slight rapidly forming refractory compounds. This 
indicates the significance of other oxidation mechanisms 
that improve the results. 
Santoke et al .  (2009)  studied the oxidative 
and reductive degradation of six fluoroquinolones, 
orbifloxacin, flumequine, marbofloxacin, danofloxacin, 
enrofloxacin, and a model compound (6-fluoro-4-oxo-
1,4-dihydro-3-quinololine carboxylic acid) through 
electron pulse radiolysis, which generate hydroxyl 
radicals, and gamma radiolysis, which generates hydrated 
electrons. The most degraded compound by hydroxyl 
radicals was marbofloxacin, followed by flumequine, 
enrofloxacin, the model compound, orbifloxacin and 
danofloxacin. The most degraded compound by hydrated 
electrons was marbofloxacin, followed by orbifloxacin, 
enrofloxacin, flumequine, danofloxacin and the model 
compound. The major degradation mechanisms arising 
from gamma irradiation of fluoroquinolone antibiotics 
appear to involve hydroxyl radical addition to the 
aromatic ring to form mixtures of phenolic compounds. 
Hydroxyl radicals can replace hydrogen atoms, fluorine 
atoms, or entire substituted piperazine rings (Santoke et 
al., 2009).
An et al. (2010) studied the advanced oxidation 
treatment of three fluoroquinolones (norfloxacin, 
levofloxacin and lomefloxacin) using TiO2 heterogeneous 
catalysis. The rate of destruction was shown to be similar 
for all three compounds. The photocatalytic degradation 
mechanisms proposed for three fluoroquinolones 
and three mechanisms, were also shown to be similar 
for all three compounds. The loss of fluoride ions 
suggested that the compounds will be more susceptible 
to biodegradation if mineralization is not achieved. 
However, most of the intermediates produced can be 
mineralized into CO2, water, and mineral species within 
180 minutes by the photocatalytic degradation process 
(An et al., 2010).
Ge et al. (2010) studied the aquatic photochemistry 
of fluoroquinolone antibiotics. In this study, eight 
fluoroquinolones (ciprofloxacin, danofloxacin, 
levofloxacin, sarafloxacin, difloxacin, enrofloxacin, 
gatifloxacin, and balofloxacin) were exposed to simulated 
sunlight. The result of solar photodegradation in 
pure water suggested that fluoroquinolones would 
intrinsically photodegrade fast in sunlight surface waters. 
However, the authors found that freshwater and seawater 
constituents, such as humic acids (HA), Fe(III), NO3-, 
and HA-Cl-, inhibited their photodegradation. This study 
found that exposure to sunlight facilitated the decay of 
fluoroquinolones in the euphotic zone of surface waters. 
However, the photolytic mechanisms and the multivariate 
role of water constituents in fluoroquinolones photolysis 
need to be taken into account when assessing the fate of 
fluoroquinolones (Ge et al., 2010).
Sturini et al. (2010) investigated the photochemical 
f a t e  o f  marbof loxac in  and  enro f loxac in ,  two 
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fluoroquinolones largely used as bactericides and present 
in surface waters. The degradation of these pollutants 
(5-50 µg L-1 starting concentration) was complete after 1 
hour of exposure to solar light. All of the primary products 
were themselves degraded after 1 hour. The reaction 
rates were scarcely affected by Ca2+ (200 mg L-1), Mg2+ 
(30 mg L-1), Cl- (30 mg L-1), and humic acid (1 mg L-1), 
but increased in the presence of phosphate (20 mg L-1). 
The fastest degradation of enrofloxacin occurred at pH 8 
where the zwitterionic form was present, while in the case 
of marbofloxacin the cationic form was the most reactive 
(Sturini et al., 2010).
Wang et al. (2010) studied the oxidation of 
seven fluoroquinolones (ciprofloxacin, enrofloxacin, 
norfloxacin, ofloxacin, lomefloxacin, pipemidic acid 
and flumequine) and three structurally related amines by 
chloride dioxide. Comparison among fluoroquinolones 
and related amines and product characterization indicated 
that piperazine rings of fluoroquinolones are the primary 
reactive center to ClO2. However, the transformation 
may not eliminate antibacterial activity because of 
the little destruction at the quinolone ring. Oxidation 
of fluoroquinolones by ClO2 leads to dealkylation, 
hydroxylation and intramolecular ring closure at 
the piperazine moiety, while leaving the quinolone 
ring mostly intact, which is strongly related to the 
antimicrobial properties of fluoroquinolones.
 The decay of fluoroquinolones by ClO2 is influenced 
by water matrices, particularly in wastewater (Wang et 
al., 2010).
Li et al. (2011) studied the photolysis of enrofloxacin 
in water under simulated sunlight irradiation using a 
Xenon lamp. After irradiation for 90 minutes, only 13.1% 
reduction in total organic carbon (TOC) occurred in spite 
of fast photolysis of 58.9% of enrofloxacin, indicating that 
enrofloxacin was transformed into intermediates without 
complete mineralization. The photolysis of enrofloxacin 
involved three main mechanisms: decarboxylation, 
defluorination, and piperazinyl N-dealkylation. The 
assay using Vibrio fischeri indicated the generation of 
intermediates with greater toxicity than enrofloxacin (Li 
et al., 2011).
Fink et al. (2012) investigated the chemical 
oxidation of enrofloxacin by hydrogen peroxide catalyzed 
by nanoparticles of copper oxide (CuO), titanium 
carbide (TiC) and silicon nitride (Si3N4). The reaction 
medium consisted of an aqueous solution of enrofloxacin 
1,000 μg L-1, 0.1 g L-1 of nanoparticles and 0.8 mol L-1 of 
hydrogen peroxide. At the reaction time of 240 minutes, 
150, 200 and 600 mg L-1 of residual enrofloxacin was 
obtained for CuO, TiC and Si3N4, respectively. The process 
catalyzed by nanoparticles was more efficient for CuO 
(Fink et al., 2012).
Sturini et al. (2012) studied the photodegradation 
by sunlight of marbofloxacin and enrofloxacin adsorbed 
in soils. Soil samples spiked with fluoroquinolones (0.5 
mg kg-1) were exposed to solar light, promoting extensive 
degradation (80%) of both drugs in 60-150 hours. The 
photodegradation of marbofloxacin resulted in the same 
efficiency and mechanisms observed in aqueous solutions, 
and involved the cleavage of the tetrahydrooxadiazine 
ring. By contrast, the same treatment applied for 
enrofloxacin resulted in fewer photoproducts than the 
number determined in aqueous solutions (those arising 
from stepwise oxidation of the piperazine side chain). 
From an environmental point of view, it is important to 
note that photodegradation mainly affects the side-chains, 
while the fluoroquinolone ring, to which the biological 
effect is associated, remains conserved up to the later 
stages of degradation (Sturini et al., 2012).
CONCLUSION
Due to the high consumption of fluoroquinolones 
and their high affinity to soil, most of these compounds 
are adsorbed on sludge from WWTPs. With the common 
practice of using this sludge as fertilizer, fluoroquinolones 
may be transferred to plants, entering the human food chain. 
For this reason, it is necessary to develop effective treatments 
for the destruction or inactivation of these compounds. 
According to studies, the degradation of fluoroquinolones 
adsorbed in soil is possible; however, more than one AOP 
would need to be evaluated concerning the generation of 
degradation products that have no antimicrobial activity, in 
order to mitigate the tendency of the emergence of bacteria 
resistant to the drugs currently in use.
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